Beruflich Dokumente
Kultur Dokumente
it Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2015 Summary Global Markets Direct s, Attention
Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2015, provides an overview of the Attention
Deficit Hyperactivity Disorder (ADHD)s therapeutic pipeline. This report provides comprehensive
information on the therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD),
complete with comparative analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players involved in the therapeutic
development for Attention Deficit Hyperactivity Disorder (ADHD) and special features on late-stage and
discontinued projects. Global Markets Directs report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
information sourced from Global Markets Directs proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct s team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box and clinical trials registries
tracking ensure that the most recent developments are captured on a real time basis. The report
enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated disease. Scope - The report provides a
snapshot of the global therapeutic landscape of Attention Deficit Hyperactivity Disorder (ADHD) - The
report reviews key pipeline products under drug profile section which includes, product description,
MoA and R&D brief, licensing and collaboration details & other developmental activities - The report
reviews key players involved in the therapeutics development for Attention Deficit Hyperactivity
Disorder (ADHD) and enlists all their major and minor projects - The report summarizes all the dormant
and discontinued pipeline projects - A review of the Attention Deficit Hyperactivity Disorder (ADHD)
products under development by companies and universities/research institutes based on information
derived from company and industry-specific sources - Pipeline products coverage based on various
stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed
assessment of monotherapy and combination therapy pipeline projects - Coverage of the Attention
Deficit Hyperactivity Disorder (ADHD) pipeline on the basis of target, MoA, route of administration and
molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides
strategically significant competitor information, analysis, and insights to formulate effective R&D
development strategies - Identify emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage - Develop strategic initiatives by
understanding the focus areas of leading companies - Identify and understand important and diverse
types of therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD) - Plan
mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise
corrective measures for pipeline projects by understanding Attention Deficit Hyperactivity Disorder
1
(ADHD) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and
expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove them from pipeline.
with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=173369/attentiondeficit-hyperactivity-disorder-adhd-pipeline-review-h2-2015
Browse
Introduction 7
Global Markets Direct Report Coverage 7
Attention Deficit Hyperactivity Disorder (ADHD) Overview 8
Therapeutics Development 9
Pipeline Products for Attention Deficit Hyperactivity Disorder (ADHD) - Overview 9
Pipeline Products for Attention Deficit Hyperactivity Disorder (ADHD) - Comparative Analysis 10
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics under Development by Companies 11
Attention Deficit Hyperactivity
Universities/Institutes 15
Disorder
(ADHD)
Therapeutics
under
Investigation
by
Read More
http://www.idatainsights.com/reports-landing-page.php?id=173369/attention-deficithyperactivity-disorder-adhd-pipeline-review-h2-2015
About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading
market research information aggregator and marketing research consulting firm. We conduct both
primary and secondary research. Our work does not end with research it is also involved in distributing
reports for different companies . We provide actionable recommendations and provide our expertise for
business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and
discovery, and then be their guide in the implementation of changes that will make a difference to their
bottom line.
ContactUs:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com
About iData Insights
We work around the clock until our clients are completely satisfied with their promised results. It is our
mission to provide timely services coupled with acute client care to create a long-lasting relationship
with you. We deliver on our promise to provide results that are essential to the success of your
company. We believe that by doing so, we will earn the trust of our clients for future projects